• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

智利因先天性甲状腺功能减退症导致的甲状腺激素合成障碍患者中 基因突变的频率。

Frequency of Mutations in the Gene in Patients with Congenital Hypothyroidism Due to Dyshormonogenesis in Chile.

机构信息

Programa de Genética Humana, Institute of Biomedical Science (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.

Vicerectoria de Investigación e Innovación, Universidad Arturo Prat, Iquique 1110939, Chile.

出版信息

Medicina (Kaunas). 2024 Jul 16;60(7):1145. doi: 10.3390/medicina60071145.

DOI:10.3390/medicina60071145
PMID:39064575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11279067/
Abstract

: Congenital thyroid dyshormonogenesis is caused by alterations in the synthesis of thyroid hormones in a newborn. Additionally, 10 to 20% of these cases are hereditary, caused by defects in proteins involved in hormonal synthesis. One of the most common causes is mutations in the thyroid peroxidase (TPO) enzyme gene, an autosomal recessive disease. We aimed to detect mutations of the gene in 12 Chilean patients with congenital hypothyroidism due to dyshormonogenesis (CHD) and to characterize these patients clinically and molecularly. : Twelve patients under 20 years of age with CHD, controlled at San Juan de Dios Hospital in Santiago, Chile, were selected according to the inclusion criteria: elevated neonatal TSH, persistent hypothyroidism, and thyroid normotopic by imaging study. Those with deafness, Down syndrome, and central or transient congenital hypothyroidism were excluded. Blood samples were taken for DNA extraction, and the 17 exons and exon-intron junctions of the gene were amplified by PCR. The PCR products were sequenced by Sanger. : Two possibly pathogenic mutations of the gene were detected: c.2242G>A (p.Val748Met) and c.1103C>T (p.Pro368Leu). These mutations were detected in 2 of 12 patients (16.6%): 1 was compound heterozygous c.1103C>T/c.2242G>A, and the other was heterozygous for c.2242G>A. In the diagnostic confirmation test, both patients presented diffuse hyper-uptake goiter on thyroid scintigraphy and high TSH in venous blood (>190 uIU/mL). : The frequency of patients with possibly pathogenic mutations in with CHD was 16.6%. Its study would allow for genetic counseling to be offered to the families of affected patients.

摘要

先天性甲状腺功能减退症是由新生儿甲状腺激素合成异常引起的。此外,这些病例中有 10%到 20%是遗传性的,是由激素合成相关蛋白的缺陷引起的。最常见的原因之一是甲状腺过氧化物酶(TPO)酶基因的突变,这是一种常染色体隐性疾病。我们旨在检测 12 例智利先天性甲状腺功能减退症(CHD)患者中基因的突变,并对这些患者进行临床和分子特征分析。

我们选择了 12 例在智利圣地亚哥的 San Juan de Dios 医院接受 CHD 治疗的年龄在 20 岁以下的患者,根据纳入标准入选:新生儿 TSH 升高、持续性甲状腺功能减退症和影像学研究提示甲状腺正常位置。排除患有耳聋、唐氏综合征和中枢或暂时性先天性甲状腺功能减退症的患者。采集血样提取 DNA,通过 PCR 扩增基因的 17 个外显子和外显子-内含子接头。通过 Sanger 测序对 PCR 产物进行测序。

我们检测到了基因的两个可能致病的突变

c.2242G>A(p.Val748Met)和 c.1103C>T(p.Pro368Leu)。这两种突变在 12 例患者中的 2 例(16.6%)中发现:1 例为复合杂合子 c.1103C>T/c.2242G>A,另 1 例为杂合子 c.2242G>A。在诊断确认试验中,两名患者的甲状腺闪烁扫描均表现为弥漫性高摄取性甲状腺肿,静脉血 TSH 升高(>190 uIU/mL)。

患有 CHD 的患者中可能存在致病突变的频率为 16.6%。对其进行研究可以为受影响患者的家属提供遗传咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c2/11279067/b86e98da3dfc/medicina-60-01145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c2/11279067/3cf17837bec4/medicina-60-01145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c2/11279067/b86e98da3dfc/medicina-60-01145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c2/11279067/3cf17837bec4/medicina-60-01145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6c2/11279067/b86e98da3dfc/medicina-60-01145-g003.jpg

相似文献

1
Frequency of Mutations in the Gene in Patients with Congenital Hypothyroidism Due to Dyshormonogenesis in Chile.智利因先天性甲状腺功能减退症导致的甲状腺激素合成障碍患者中 基因突变的频率。
Medicina (Kaunas). 2024 Jul 16;60(7):1145. doi: 10.3390/medicina60071145.
2
Congenital goitrous primary hypothyroidism in two German families caused by novel thyroid peroxidase (TPO) gene mutations.两个德国家庭中由新型甲状腺过氧化物酶(TPO)基因突变引起的先天性甲状腺肿性原发性甲状腺功能减退症。
Exp Clin Endocrinol Diabetes. 2013 Jun;121(6):343-6. doi: 10.1055/s-0033-1333766. Epub 2013 Mar 19.
3
Mutation screening of the TPO gene in a cohort of 192 Chinese patients with congenital hypothyroidism.对192例中国先天性甲状腺功能减退症患者队列进行甲状腺过氧化物酶(TPO)基因突变筛查。
BMJ Open. 2016 May 12;6(5):e010719. doi: 10.1136/bmjopen-2015-010719.
4
[Mutation of thyroid peroxidase gene in 35 patients with congenital hypothyroidism].35例先天性甲状腺功能减退症患者甲状腺过氧化物酶基因突变情况
Zhonghua Er Ke Za Zhi. 2011 Aug;49(8):626-30.
5
Final diagnosis in children with subclinical hypothyroidism and mutation analysis of the thyroid peroxidase gene (TPO).亚临床甲状腺功能减退症患儿的最终诊断及甲状腺过氧化物酶基因(TPO)突变分析
J Pediatr Endocrinol Metab. 2009 Sep;22(9):845-51. doi: 10.1515/jpem.2009.22.9.845.
6
The TPO mutation screening and genotype-phenotype analysis in 230 Chinese patients with congenital hypothyroidism.230 例先天性甲状腺功能减退症患者的 TPO 基因突变筛查及表型-基因型分析。
Mol Cell Endocrinol. 2020 Apr 15;506:110761. doi: 10.1016/j.mce.2020.110761. Epub 2020 Feb 20.
7
Segregation of S292F TPO gene mutation in three large Tunisian families with thyroid dyshormonogenesis: evidence of a founder effect.S292F甲状腺过氧化物酶(TPO)基因突变在三个突尼斯甲状腺激素合成障碍大家族中的分离:奠基者效应的证据
Eur J Pediatr. 2015 Nov;174(11):1491-501. doi: 10.1007/s00431-015-2550-4. Epub 2015 May 13.
8
Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.苏丹先天性甲状腺功能减退症儿童中 TG 和 TPO 突变的患病率增加。
J Clin Endocrinol Metab. 2020 May 1;105(5):1564-72. doi: 10.1210/clinem/dgz297.
9
A truncating TPO mutation (Y55X) in patients with hypothyroidism and total iodide organification defect.甲状腺功能减退症和全碘有机化缺陷患者中的一种截短型促甲状腺素原(TPO)突变(Y55X)
Endocr Res. 2015;40(3):146-50. doi: 10.3109/07435800.2014.967354. Epub 2014 Oct 20.
10
Case Report: Functional Analysis and Neuropsychological Evaluation of Dyshormonogenetic Fetal Goiter in Siblings Caused by Novel Compound Hyterozygous TPO Gene Mutations.病例报告:新型复合杂合 TPO 基因突变致胎儿甲状腺肿的同胞兄妹的功能分析与神经心理学评估。
Front Endocrinol (Lausanne). 2021 Jun 18;12:671659. doi: 10.3389/fendo.2021.671659. eCollection 2021.

引用本文的文献

1
Exon 11 Polymorphism (rs1126797) in the Thyroid Peroxidase () Gene Among Caucasian Polish Patients with Autoimmune Thyroiditis: A Short Communication.白种波兰自身免疫性甲状腺炎患者甲状腺过氧化物酶()基因外显子11多态性(rs1126797):一篇简短通讯
Int J Mol Sci. 2025 Jun 30;26(13):6299. doi: 10.3390/ijms26136299.
2
Genetics of primary congenital hypothyroidism: three decades of discoveries and persisting etiological challenges.原发性先天性甲状腺功能减退症的遗传学:三十年的发现与持续存在的病因挑战
Eur Thyroid J. 2025 Mar 28;14(2). doi: 10.1530/ETJ-24-0348. Print 2025 Apr 1.

本文引用的文献

1
Insights on variant analysis tools for pathogenicity prediction.关于致病性预测的变异分析工具的见解。
Front Genet. 2022 Nov 29;13:1010327. doi: 10.3389/fgene.2022.1010327. eCollection 2022.
2
Mutational screening of the TPO and DUOX2 genes in Argentinian children with congenital hypothyroidism due to thyroid dyshormonogenesis.对甲状腺激素生成障碍导致先天性甲状腺功能减退的阿根廷儿童进行 TPO 和 DUOX2 基因突变筛查。
Endocrine. 2022 Jun;77(1):86-101. doi: 10.1007/s12020-022-03054-3. Epub 2022 May 4.
3
Evaluating the impact of in silico predictors on clinical variant classification.
评估计算机预测因子对临床变异分类的影响。
Genet Med. 2022 Apr;24(4):924-930. doi: 10.1016/j.gim.2021.11.018. Epub 2021 Dec 23.
4
Genetics of primary congenital hypothyroidism-a review.原发性先天性甲状腺功能减退症的遗传学研究进展:综述
Hormones (Athens). 2021 Jun;20(2):225-236. doi: 10.1007/s42000-020-00267-x. Epub 2021 Jan 5.
5
Clinical and genetic investigation of 136 Japanese patients with congenital hypothyroidism.136 例先天性甲状腺功能减退症日本患者的临床和遗传学研究。
J Pediatr Endocrinol Metab. 2020 May 29;33(6):691-701. doi: 10.1515/jpem-2019-0433.
6
Mutation spectrum analysis of 29 causative genes in 43 Chinese patients with congenital hypothyroidism.29 个致病变异基因在 43 例中国先天性甲状腺功能减退症患者中的突变谱分析。
Mol Med Rep. 2020 Jul;22(1):297-309. doi: 10.3892/mmr.2020.11078. Epub 2020 Apr 16.
7
The TPO mutation screening and genotype-phenotype analysis in 230 Chinese patients with congenital hypothyroidism.230 例先天性甲状腺功能减退症患者的 TPO 基因突变筛查及表型-基因型分析。
Mol Cell Endocrinol. 2020 Apr 15;506:110761. doi: 10.1016/j.mce.2020.110761. Epub 2020 Feb 20.
8
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
9
Clinical genetics of congenital hypothyroidism.先天性甲状腺功能减退症的临床遗传学
Endocr Dev. 2014;26:60-78. doi: 10.1159/000363156. Epub 2014 Aug 29.
10
European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.欧洲儿科内分泌学会关于先天性甲状腺功能减退症筛查、诊断和管理的共识指南。
J Clin Endocrinol Metab. 2014 Feb;99(2):363-84. doi: 10.1210/jc.2013-1891. Epub 2014 Jan 21.